Dexco Statistics

Total Valuation

Dexco has a market cap or net worth of BRL 4.45 billion. The enterprise value is 10.41 billion.

Market Cap	4.45B
Enterprise Value	10.41B

Important Dates

The next estimated earnings date is Wednesday, May 7, 2025.

Earnings Date	May 7, 2025
Ex-Dividend Date	Mar 18, 2025

Share Statistics

Dexco has 808.36 million shares outstanding. The number of shares has increased by 0.05% in one year.

Current Share Class	n/a
Shares Outstanding	808.36M
Shares Change (YoY)	+0.05%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	20.71%
Owned by Institutions (%)	19.15%
Float	306.18M

Valuation Ratios

The trailing PE ratio is 25.92 and the forward PE ratio is 10.24.

PE Ratio	25.92
Forward PE	10.24
PS Ratio	0.54
PB Ratio	0.64
P/TBV Ratio	0.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.41, with an EV/FCF ratio of -232.05.

EV / Earnings	60.40
EV / Sales	1.26
EV / EBITDA	6.41
EV / EBIT	24.55
EV / FCF	-232.05

Financial Position

The company has a current ratio of 1.39, with a Debt / Equity ratio of 1.07.

Current Ratio	1.39
Quick Ratio	0.93
Debt / Equity	1.07
Debt / EBITDA	4.54
Debt / FCF	-171.78
Interest Coverage	0.64

Financial Efficiency

Return on equity (ROE) is 2.54% and return on invested capital (ROIC) is 2.11%.

Return on Equity (ROE)	2.54%
Return on Assets (ROA)	1.72%
Return on Invested Capital (ROIC)	2.11%
Return on Capital Employed (ROCE)	3.43%
Revenue Per Employee	578,763
Profits Per Employee	12,118
Employee Count	14,228
Asset Turnover	0.46
Inventory Turnover	3.88

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -28.72% in the last 52 weeks. The beta is 0.93, so Dexco's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-28.72%
50-Day Moving Average	5.87
200-Day Moving Average	6.98
Relative Strength Index (RSI)	40.95
Average Volume (20 Days)	2,581,844

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dexco had revenue of BRL 8.23 billion and earned 172.41 million in profits. Earnings per share was 0.21.

Revenue	8.23B
Gross Profit	2.05B
Operating Income	497.08M
Pretax Income	344.47M
Net Income	172.41M
EBITDA	1.62B
EBIT	497.08M
Earnings Per Share (EPS)	0.21

Full Income Statement

Balance Sheet

The company has 1.81 billion in cash and 7.71 billion in debt, giving a net cash position of -5.74 billion or -7.10 per share.

Cash & Cash Equivalents	1.81B
Total Debt	7.71B
Net Cash	-5.74B
Net Cash Per Share	-7.10
Equity (Book Value)	7.20B
Book Value Per Share	8.63
Working Capital	1.42B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.28 billion and capital expenditures -1.33 billion, giving a free cash flow of -44.88 million.

Operating Cash Flow	1.28B
Capital Expenditures	-1.33B
Free Cash Flow	-44.88M
FCF Per Share	-0.06

Full Cash Flow Statement

Margins

Gross margin is 24.90%, with operating and profit margins of 6.04% and 2.09%.

Gross Margin	24.90%
Operating Margin	6.04%
Pretax Margin	4.18%
Profit Margin	2.09%
EBITDA Margin	19.68%
EBIT Margin	6.04%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 3.91%.

Dividend Per Share	0.22
Dividend Yield	3.91%
Dividend Growth (YoY)	-81.61%
Years of Dividend Growth	n/a
Payout Ratio	135.64%
Buyback Yield	-0.05%
Shareholder Yield	3.85%
Earnings Yield	3.87%
FCF Yield	-1.01%

Dividend Details

Stock Splits

The last stock split was on December 21, 2022. It was a forward split with a ratio of 1.1.

Last Split Date	Dec 21, 2022
Split Type	Forward
Split Ratio	1.1

Scores

Dexco has an Altman Z-Score of 1.16. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.16
Piotroski F-Score	n/a